NeuroOne Medical Technologies: Key Financial Announcement
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) is making headlines as it prepares to share its financial performance for the fiscal fourth quarter and the entire year ending September 30, 2024. This report will be unveiled on December 17, when the market opens, which is crucial for stakeholders and analysts keen on understanding the company's trajectory.
Investor Conference Call and Webcast Details
Following the press release of their financial results, NeuroOne will conduct a comprehensive conference call and webcast at 9:00 a.m. Eastern time. This event is pivotal, offering insights into the Company's performance, updates on their ongoing projects, and an interactive Q&A session to engage directly with investors.
How to Participate in the Conference Call
Investors interested in the call should ensure they dial in at least five minutes early. Here are the details for participation:
- Date: December 17
- Time: 9:00 a.m. Eastern time
- U.S. Dial-In: 888-506-0062 (Toll-Free)
- International Dial-In: 973-528-0011
- Access Code: 603219
Playback Availability
For those unable to attend the live session, a playback will be accessible until December 31. This can be a valuable opportunity to catch up on the insights shared during the call. The playback numbers are:
- U.S. Playback: 877-481-4010
- International Playback: 919-882-2331
- Replay Passcode: 51728
About NeuroOne and Its Innovations
NeuroOne Medical Technologies Corporation aims to revolutionize surgical care with minimally invasive and high-definition solutions designed for EEG recording, brain stimulation, and ablation procedures. Their focus on enhancing outcomes for patients suffering from various neurological conditions like epilepsy, Parkinson’s disease, and chronic pain is commendable and positions them as innovators in this niche market.
Future Potential and Market Applications
The Company is not limiting its innovations to current applications; there is a future vision targeting additional areas such as depression, high blood pressure, and artificial intelligence. This willingness to explore diverse therapeutic possibilities demonstrates their commitment to improving patient care and potentially reducing healthcare costs.
Connecting with NeuroOne
For investors or interested parties wishing to learn more, the Company encourages reaching out via their website. Key contact for Investor Relations is:
MZ Group – MZ North America
Email: NMTC@mzgroup.us
Frequently Asked Questions
When will NeuroOne release its financial results?
NeuroOne will announce its financial results on December 17 before market opens.
Will there be a conference call to discuss the results?
Yes, a conference call will take place at 9:00 a.m. Eastern time on December 17.
How can I participate in the conference call?
Participants can join via U.S. toll-free number, international dial-in, or through a link provided just before the event.
What are some conditions that NeuroOne is focusing on?
NeuroOne is addressing conditions like epilepsy, Parkinson's disease, chronic pain, among others through its innovative technologies.
How can I contact Investor Relations for more information?
Investors can reach out to MZ Group at NMTC@mzgroup.us for inquiries.
